(Q44106427)

English

IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients

scientific article published on 25 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

0 references

Markus Peck-Radosavljevic

7

object named as

Markus Peck-Radosavljevic

0 references

author name string

Berit A Payer

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Thomas Reiberger

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Judith Aberle

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Peter Ferenci

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Heidemarie Holzmann

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Armin Rieger

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Vienna HIV-HCV study group

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

European Journal of Clinical Investigation

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

599-606

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

HIV and hepatitis C coinfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

A catalogue of reporting guidelines for health research

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02623.X

21 January 2018

Identifiers

10.1111/J.1365-2362.2011.02623.X

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44106427&oldid=2106643648"